<DOC>
	<DOCNO>NCT02080494</DOCNO>
	<brief_summary>Tranexamic acid antifibrinolytic drug use decrease post-operative blood loss . This study prospective , randomize control trial investigating use tranexamic acid fracture surgery around hip knee , significant blood loss ( &gt; 300mL ) expect . The hypothesis study tranexamic acid associate decrease post-operative blood loss , well decrease need allogenic blood transfusion , patient fracture surgery around hip knee .</brief_summary>
	<brief_title>Tranexamic Acid Orthopaedic Trauma Surgery</brief_title>
	<detailed_description />
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Tranexamic Acid</mesh_term>
	<criteria>Patients isolated fracture pelvic ring , acetabulum , femur tibia require open reduction internal fixation Expected blood loss great 300 mL Age â‰¥ 18 Skeletal maturity Pregnant breastfeeding Patients take oral contraceptive Contraindication venous thromboembolic event ( VTE ) prophylaxis ( intracranial , intrathoracic , intraabdominal bleeding spine fracture ) Patients require operative intervention injury ( orthopaedic nonorthopaedic ) Known hypercoagulable state include history prescribe anticoagulation ( warfarin , plavix , low molecular weight heparin ) Renal Insufficiency ( creatinine great 1.5mg/dL ) Open fracture</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>tranexamic acid</keyword>
	<keyword>orthopaedic trauma</keyword>
	<keyword>pelvic fracture</keyword>
	<keyword>hip fracture</keyword>
	<keyword>femur fracture</keyword>
	<keyword>blood loss</keyword>
</DOC>